Avid Bioservices Inc (CDMO)

[vp_007_99]

Several hedge funds have recently added to their stakes in the stock. Paloma Partners Management Co bought a new stake in Peregrine Pharmaceuticals during the second quarter worth about $311,000. Laurion Capital Management LP bought a new stake in Peregrine Pharmaceuticals during the second quarter worth about $242,000. Eqis Capital Management Inc. raised its stake in Peregrine Pharmaceuticals by 6.0% in the second quarter. Eqis Capital Management Inc. now owns 1,508,352 shares of the biopharmaceutical company’s stock worth $543,000 after buying an additional 86,038 shares during the last quarter. Jacobs Levy Equity Management Inc. raised its stake in Peregrine Pharmaceuticals by 173.7% in the first quarter. Jacobs Levy Equity Management Inc. now owns 1,009,400 shares of the biopharmaceutical company’s stock worth $424,000 after buying an additional 640,570 shares during the last quarter. Finally, Geode Capital Management LLC raised its stake in Peregrine Pharmaceuticals by 14.9% in the first quarter. Geode Capital Management LLC now owns 1,394,436 shares of the biopharmaceutical company’s stock worth $586,000 after buying an additional 180,349 shares during the last quarter. Institutional investors own 13.81% of the company’s stock.
http://www.nationaldailypress.com/2016/09/13/peregrine-pharmaceuticals-inc-pphm-given-outperform-rating-at-fbr-co/